Clinical and Translational Medicine
Hanwool Jeon, Hayeong Kang, Jihyun Im, Suin Jo, Hyunchul Jung, Moinay Kim, Jae Hyun Kim, Eunyeup Lee, Soyoung Kim, Jeong Hoon Kim, Chang-Ki Hong, Young-Hoon Kim, Sang Woo Song, Jinha Park, Sang-Yeob Kim, Seungjoo Lee
Dear Editor,Glioblastoma (GBM), the most aggressive malignanttumour, is increasingly treated with immunotherapy.1–3The stimulator of interferon genes (STING) pathway4is key to tumour immunity and a studied target forimmunotherapy.5 This study explores the immune land-scape of GBM, focusing on spatial relationships betweentumour-associated immune cells (TAICs) 6 and STING-expressing cells, uncovering patterns linked to prognosis.

서울아산병원 이승주교수님 연구실 202501작성
Comments